Provided by Tiger Fintech (Singapore) Pte. Ltd.

OCUMENSION-B

8.590
+0.1802.14%
Volume:495.50K
Turnover:4.18M
Market Cap:7.00B
PE:-20.09
High:8.640
Open:8.260
Low:8.110
Close:8.410
52wk High:12.230
52wk Low:3.620
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:0.72
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.428
ROE:-7.76%
ROA:-5.07%
PB:1.76
PE(LYR):-20.09
PS:11.81

Loading ...

Stock Track | Ocumension Therapeutics Plummets 5.19% as H1 2025 Earnings Miss Estimates

Stock Track
·
Aug 27

CICC Maintains Outperform Rating on OCUMENSION-B (01477), Raises Target Price to HK$10.16

Stock News
·
Aug 27

Funds Seek Bull Market Value Opportunities as China's Largest Medical ETF (512170) Trades at High Premium! Pharmaceutical Sector Fundamentals Remain Strong with Multiple Stocks Showing Doubled Earnings Growth

Deep News
·
Aug 26

BeiGene Secures $950 Million Overseas Deal, Rewriting BD Transaction Logic as CSPC, Qilu Pharma and Others Accelerate Market Positioning

Deep News
·
Aug 26

ASCLETIS-B (01672) Issues 28.82 Million Shares on August 25

Stock News
·
Aug 25

UK Drug Pricing Negotiations Collapse as Pharmaceutical Industry Warns of Investment Risk

Stock News
·
Aug 22

Ocumension Therapeutics Logs Lower Losses in H1; Eye Drug Meets Trial Goal

MT Newswires Live
·
Aug 22

Hong Kong Stock Alert | SINO BIOPHARM (01177) Surges Over 6% Again as Zonartinib Receives CDE Breakthrough Therapy Designation, H1 Results Exceed Market Expectations

Stock News
·
Aug 22

RMB 420 Billion Pharmaceutical Giant Posts Strong Earnings as Only On-Market Pharmaceutical ETF (562050) Hits New Closing High! Top Officials Voice Support for Biomedical Industry

Deep News
·
Aug 21

OCUMENSION-B (01477) Reports Interim Results with Net Loss of RMB 132 Million, Narrowing 12.6% Year-on-Year

Stock News
·
Aug 21

OCUMENSION-B (01477): OT-301's Second Phase III Clinical Trial Achieves Primary Endpoint

Stock News
·
Aug 21

Ocumension Therapeutics H1 Gross Profit RMB 105.6 Million

THOMSON REUTERS
·
Aug 21

Japanese Stock Market Falls for Third Consecutive Day as Auto and Pharmaceutical Stocks Decline

Deep News
·
Aug 21

Xiang Xue Pharmaceutical Co.,Ltd. (300147) Faces Penalties, Shareholders May Seek Compensation

Deep News
·
Aug 20

IPO News | Bestear Pharmaceuticals Reportedly Considers Hong Kong Listing, Aims to Raise Approximately $300 Million

Stock News
·
Aug 19

Rebuilding Growth Engines: Global Pharmaceutical Executive AI Strategy Workshop

Deep News
·
Aug 19

Healthcare and Pharmaceutical Sectors Rally! Medical ETF (512170) Hits Annual High, Inner Mongolia Furui Medical Science Co.,Ltd. Sees Second Consecutive 20% Daily Limit Up! Innovation Drug Momentum Continues as Market's Only Pharmaceutical ETF Reaches New Listing High

Deep News
·
Aug 19

OCUMENSION-B (01477) Issues 1.5325 Million Shares Under Stock Plan

Stock News
·
Aug 18

Hong Kong Stock Alert | ASCLETIS-B (01672) Rises Over 3% as Interim Shareholder Losses Narrow 32.5% YoY, ASC30 US Phase Ib Study Shows Positive Data

Stock News
·
Aug 18

ASCLETIS-B (01672): ASC47 Combined with GLP-1R/GIPR Dual Receptor Agonist Peptide ASC31 Demonstrates Superior Weight Loss Effects Compared to ASC47 Plus Tirzepatide Combination in Obese Animal Models

Stock News
·
Aug 18